What is the recommended treatment for herpes simplex virus (HSV) infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Herpes Simplex Virus (HSV) Infections

The recommended first-line treatment for HSV infections is valacyclovir 1000 mg three times daily for 7 days, acyclovir 800 mg five times daily for 7 days, or famciclovir 500 mg three times daily for 7 days. 1

Antiviral Therapy Options

First-line Treatments

  • Valacyclovir: 1000 mg three times daily for 7 days
  • Acyclovir: 800 mg five times daily for 7 days
  • Famciclovir: 500 mg three times daily for 7 days

Treatment Duration

  • Standard treatment duration is 7 days for immunocompetent patients
  • For immunocompromised patients, treatment should continue until complete healing of lesions 1

Special Considerations

Timing of Treatment

  • Treatment should be initiated within 72 hours of symptom onset for maximum effectiveness
  • Some evidence suggests valacyclovir may still provide benefit when started after 72 hours 1

Renal Dose Adjustments

For patients with renal impairment, dose adjustments are necessary:

Valacyclovir adjustments:

Creatinine Clearance (mL/min) Dosing Adjustment
≥50 (normal) No adjustment needed
30-49 No adjustment needed
10-29 500 mg every 24 hours
<10 500 mg every 24 hours

Acyclovir adjustments:

Creatinine Clearance (mL/min) Dosing Adjustment
>25 800 mg every 4 hours, 5x daily
10-25 800 mg every 8 hours
<10 800 mg every 12 hours

1

Treatment by Patient Population

Immunocompromised Patients

  • Higher doses may be required for immunocompromised patients
  • For HIV-infected patients with CD4+ count ≥100 cells/mm³, higher doses of oral antivirals are recommended 1
  • In the event of severe HSV disease during immunomodulator therapy:
    • Initiate antiviral therapy
    • Discontinue immunomodulators until symptoms improve 2

Pediatric Patients

  • Valacyclovir is indicated for cold sores in patients ≥12 years
  • Not established for genital herpes or herpes zoster in patients <18 years 3
  • For children under 45 kg with herpes zoster, acyclovir 20 mg/kg body weight (maximum 800 mg/dose) orally 4 times daily for 7-10 days is recommended 1

Recurrent HSV Infections

  • For patients with recurrent attacks, suppressive therapy should be considered:
    • Aciclovir 400 mg twice daily
    • Valaciclovir 500 mg daily
    • Famciclovir 250 mg twice daily 2

Specific Clinical Scenarios

Ophthalmic HSV

  • Requires ophthalmology consultation to prevent long-term vision loss
  • Specialist review and advice should be sought for patients with prior HSV keratitis 2, 1

HSV Colitis

  • Very rare even in IBD patients but can mimic acute relapse
  • Should be excluded by immunohistochemistry or tissue PCR before increasing immunomodulator therapy 2

Severe or Life-Threatening HSV

  • For severe systemic infections:
    • Intravenous aciclovir or foscarnet
    • Discontinuation of immunosuppressants
    • Careful multidisciplinary management 2

Symptomatic Relief

  • Topical 5% acyclovir cream applied 5 times daily for 4 days
  • Topical anesthetics, warm sitz baths, oral analgesics
  • Keep lesions clean and dry 1

Patient Education

  • Apply medication at the first sign of prodrome
  • Wash hands before and after application
  • Continue treatment for the full prescribed duration even if symptoms improve
  • Practice abstinence during outbreaks or prodromal symptoms
  • Use condoms consistently to reduce transmission risk 1

Emerging Treatments

While not yet standard of care, helicase-primase inhibitors (amenamevir and pritelivir) are showing promise in clinical trials for treatment of HSV infections 4. Single-day high-dose regimens (such as famciclovir 1500 mg single dose for herpes labialis) have also shown effectiveness and may improve compliance 5.

Common Pitfalls to Avoid

  • Delayed treatment: Initiating treatment after 72 hours significantly reduces efficacy
  • Inadequate dose adjustments: Failure to adjust doses in renal impairment can lead to toxicity
  • Premature discontinuation: Stopping treatment before the full course can lead to treatment failure
  • Missing HSV colitis: Failing to consider HSV as a cause of refractory IBD can lead to inappropriate escalation of immunosuppression 2

References

Guideline

Shingles Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

HSV antivirals - current and future treatment options.

Current opinion in virology, 2016

Research

New approaches to the therapy of HSV infections.

Herpes : the journal of the IHMF, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.